Keyphrases
Left Ventricular Assist Device
93%
Database Analysis
83%
Heart Failure
65%
Risk Prediction Model
54%
Cardiac Allograft
53%
Heart Transplant Recipients
49%
Peripheral Arterial Disease
45%
Odds Ratio
42%
Hazard Ratio
41%
UNOS Database
41%
Myosin-binding Protein C
41%
TriNetX
41%
Pathophysiology
37%
Heart Failure with Preserved Ejection Fraction (HFpEF)
35%
Cardiac Transplantation
34%
Risk Factors
34%
Transplant Patients
33%
MicroRNA
33%
Ventricular Assist Device
32%
Diastolic Dysfunction
32%
ErbB
31%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
30%
Gastrointestinal Bleeding
29%
Skin Cancer
29%
United States
29%
Confidence Interval
28%
Adult Cardiac
27%
Systematic Meta-analysis
27%
Meta-analysis
27%
Substance Use Disorder
27%
Mental Health
27%
Bridge to Transplantation
26%
Mitochondria
25%
Liver
25%
Plasticizer
23%
Medical Therapy
23%
Cardiovascular Risk
22%
Mechanical Circulatory Support
22%
Oncogene
21%
High Risk
21%
Survival Analysis
21%
Basal Cell Carcinoma
20%
Cardiogenic Shock
20%
Transplant Waiting List
20%
Malignancy
20%
Diabetes
19%
Functional Capacity
19%
Area under the Curve
18%
Quality of Life
18%
Immunosuppression
18%
Medicine and Dentistry
Left Ventricular Assist Device
100%
Transplantation
86%
Congestive Heart Failure
71%
Allograft
53%
Heart Graft
42%
Cardiovascular Disease
40%
Heart Transplantation
35%
Heart Failure with Preserved Ejection Fraction
34%
Systematic Review
34%
Pathophysiology
32%
N(g),n(g) Dimethylarginine
31%
Ventricular Assist Device
31%
Cardiovascular System
29%
Hazard Ratio
28%
Meta-Analysis
27%
Acute Decompensated Heart Failure
27%
Mental Health
27%
Substance Abuse
27%
Dilated Cardiomyopathy
22%
Biological Marker
21%
Survival Analysis
21%
Diabetes
21%
Cardiogenic Shock
20%
Proportional Hazards Model
19%
Basal-Cell Carcinoma
19%
Odds Ratio
19%
Creatinine
19%
Immunosuppressive Treatment
19%
Diagnosis
18%
Nitric Oxide Synthase
18%
Skin Cancer
18%
Assisted Circulation
18%
Oxidative Stress
17%
Atrial Fibrillation
16%
Myocardial Disease
16%
Quality of Life
16%
Diastolic Dysfunction
15%
Apoplexy
15%
Heart Failure with Reduced Ejection Fraction
15%
Cancer
15%
Long Term Survival
14%
Infusion Therapy
13%
Arteriosclerosis Obliterans
13%
Angiotensin II Antagonist
13%
Cardiac Myosin
13%
Functional Status
13%
Disease Severity
13%
Ustekinumab
13%
Carcinogenicity
13%
Outpatient
13%